mTORC1 signaling: what we still don't know
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The mammalian target of rapamycin (mTOR) is a protein kinase that plays key roles in cellular regulation. It forms complexes with additional proteins. The best-understood one is mTOR complex 1 (mTORC1). The regulation and cellular functions of mTORC1 have been the subjects of intense study; despite this, many questions remain to be answered. They include questions about the actual mechanisms by which mTORC1 signaling is stimulated by hormones and growth factors, which involves the small GTPase Rheb, and by amino acids, which involves other GTPase proteins. The control of Rheb and the mechanism by which it activates mTORC1 remain incompletely understood. Although it has been known for many years that rapamycin interferes with some functions of mTORC1, it is not known how it does this, or why only some functions of mTORC1 are affected. mTORC1 regulates diverse cellular functions. Several mTORC1 substrates are now known, although in several cases their physiological roles are poorly or incompletely understood. In the case of several processes, although it is clear that they are regulated by mTORC1, it is not known how mTORC1 does this. Lastly, mTORC1 is implicated in ageing, but again it is unclear what mechanisms account for this. Given the importance of mTORC1 signaling both for cellular functions and in human disease, it is a high priority to gain further insights into the control of mTORC1 signaling and the mechanisms by which it controls cellular functions and animal physiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Extending Healthy Life Span—From Yeast to Humans
Fontana, L., Partridge, L., & Longo, V. D. (2010) · Science · doi:10.1126/science.1172539 · Cited by 3,023 · cited 2×
“It should be stressed here that other studies point to roles for additional processes downstream of (m)TORC1 in the regulation of lifespan (e.g. autophagy and translation initiation) (Blagosklonny and Hall, 2009; Hands et al., 2009; Fontana et al., 2010; Katewa and Kapahi, 2010).”
BackgroundThe Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., & Sabatini, D. M. (2008) · Science · doi:10.1126/science.1157535 · Cited by 2,773 · cited 3×
“For example, the RagB–GTP/RagC–GDP pairing was found to be most effective at binding mTORC1 (Sancak et al., 2008).”
BackgroundSancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A. L., Nada, S., & Sabatini, D. M. (2010) · Cell · doi:10.1016/j.cell.2010.02.024 · Cited by 2,464 · cited 3×
“Recent data indicate that it is activated on the surface of lysosomes (Sancak et al., 2010).”
BackgroundJung, C. H., Ro, S.-H., Cao, J., Otto, N. M., & Kim, D.-H. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.017 · Cited by 2,090
Nutrient-dependent mTORC1 Association with the ULK1–Atg13–FIP200 Complex Required for Autophagy
Hosokawa, N., Hara, T., Kaizuka, T., Kishi, C., Takamura, A., Miura, Y., Iemura, S.-I., Natsume, T., Takehana, K., Yamada, N., et al. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-12-1248 · Cited by 2,076 · cited 2×
“Furthermore, mTORC1 phosphorylates the Atg1 homologs ULK1/2 (Ganley et al., 2009; Hosokawa et al., 2009; Jung et al., 2009) (Figure 4) and this appears to repress their activities.”
BackgroundULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy Machinery
Jung, C. H., Jun, C. B., Ro, S.-H., Kim, Y.-M., Otto, N. M., Cao, J., Kundu, M., & Kim, D.-H. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-12-1249 · Cited by 2,025 · cited 2×
“Furthermore, mTORC1 phosphorylates the Atg1 homologs ULK1/2 (Ganley et al., 2009; Hosokawa et al., 2009; Jung et al., 2009) (Figure 4) and this appears to repress their activities.”
BackgroundThoreen, C. C., Kang, S. A., Chang, J. W., Liu, Q., Zhang, J., Gao, Y., Reichling, L. J., Sim, T., Sabatini, D. M., & Gray, N. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900301200 · Cited by 1,803
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., et al. (2004) · Nature · doi:10.1038/nature02866 · Cited by 1,677 · cited 3×
“Also potentially relevant for human health, S6Ks can negatively regulate insulin signaling through the phosphorylation of insulin receptor substrate 1 (IRS1) and which impairs PI3K/Akt signaling downstream of the insulin receptor (Harrington et al., 2004; Um et al., 2004; Shah and Hunter, 2006), although there is disa…”
BackgroundmTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex
Cunningham, J. T., Rodgers, J. T., Arlow, D. H., Vazquez, F., Mootha, V. K., & Puigserver, P. (2007) · Nature · doi:10.1038/nature06322 · Cited by 1,488 · cited 2×
“The co-activation of YY1 by PGC1a is inhibited by rapamycin (Cunningham et al., 2007), leading to repression of many mitochondrial genes.”
BackgroundSREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth
Porstmann, T., Santos, C. R., Griffiths, B., Cully, M., Wu, M., Leevers, S., Griffiths, J. R., Chung, Y.-L., & Schulze, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.007 · Cited by 1,413
Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384 · cited 2×
“, 2001), it was proposed that depletion of cellular ATP would decrease the activity of mTOR by a simple Michaelis–Menten effect, but such a mechanism would only likely come into play if ATP levels fell drastically (to levels at which cells could very likely not survive), thus severely compromising both the pro-surviva…”
BackgroundRegulation of TORC1 by Rag GTPases in nutrient response
Kim, E., Goraksha-Hicks, P., Li, L., Neufeld, T. P., & Guan, K.-L. (2008) · Nature Cell Biology · doi:10.1038/ncb1753 · Cited by 1,349 · cited 1×
“Sancak et al. (2008) found RagC as an interaction partner for raptor, while Kim et al. (2008) came across the orthologs of the Rag GTPases by conducting a screen for small GTPases that control TOS in Drosophila, where these proteins play key roles in cell growth and cell viability under conditions…”
p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
Budanov, A. V., & Karin, M. (2008) · Cell · doi:10.1016/j.cell.2008.06.028 · Cited by 1,326 · cited 1×
“Conversely, there is evidence that p53 negatively regulates mTORC1 signaling, perhaps through sestrins, which are encoded by p53 target genes (Horton et al., 2002; Budanov and Karin, 2008).”
BackgroundPhosphorylation and Functional Inactivation of TSC2 by Erk
Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., & Pandolfi, P. P. (2005) · Cell · doi:10.1016/j.cell.2005.02.031 · Cited by 1,268 · cited 2×
“Phosphorylation of TSC2 by ERK may play a role here (Ma et al., 2005), although TSC2 appears to be a very poor substrate for ERK, at least in vitro (Rolfe et al.”
The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
Huang, J., & Manning, B. D. (2008) · Biochemical Journal · doi:10.1042/bj20080281 · Cited by 1,237 · cited 7×
“Rheb can activate mTORC1 signaling when in its GTP-bound state (Huang and Manning, 2008).”
BackgroundInfluentialPRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Sancak, Y., Thoreen, C. C., Peterson, T. R., Lindquist, R. A., Kang, S. A., Spooner, E., Carr, S. A., & Sabatini, D. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.003 · Cited by 1,236 · cited 8×
“How do they do this? How do they evade the inhibitory action of PRAS40? Although knocking down PRAS40 expression is reported (as expected from the above model) to promote mTORC1 signaling in serum- or amino acid-starved cells (Oshiro et al., 2007; Sancak et al., 2007; Wang et al., 2007), another study reported that th…”
BackgroundInfluentialRibosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span
Selman, C., Tullet, J. M. A., Wieser, D., Irvine, E., Lingard, S. J., Choudhury, A. I., Claret, M., Al-Qassab, H., Carmignac, D., Ramadani, F., et al. (2009) · Science · doi:10.1126/science.1177221 · Cited by 1,120 · cited 1×
“Mice in which S6K1 has been knocked out showed extended life spans (Selman et al., 2009).”
BackgroundPhosphatidic Acid-Mediated Mitogenic Activation of mTOR Signaling
Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A., & Chen, J. (2001) · Science · doi:10.1126/science.1066015 · Cited by 1,055
Rheb Binds and Regulates the mTOR Kinase
Long, X., Lin, Y., Ortiz-Vega, S., Yonezawa, K., & Avruch, J. (2005) · Current Biology · doi:10.1016/j.cub.2005.02.053 · Cited by 1,005 · cited 5×
“Nonetheless, it is well-established that overexpressing Rheb can fully activate mTORC1 signaling in cells deprived of external amino acids (Long et al., 2005a), suggesting that the mechanisms by which amino acids activate mTORC1 are somehow linked with the mechanism by which Rheb does this.”
BackgroundInfluentialMammalian TOR: a homeostatic ATP sensor
Dennis, P. B., Jaeschke, A., Saitoh, M., Fowler, B., Kozma, S. C., & Thomas, G. (2001) · Science · doi:10.1126/science.1063518 · Cited by 962
García-Martínez, J. M., & Alessi, D. R. (2008) · Biochemical Journal · doi:10.1042/bj20081668 · Cited by 907 · cited 2×
“This implies that PI3K somehow activates mTORC2 (Garcia-Martinez and Alessi, 2008) but it is not clear whether this is mediated through a change in mTORC2’s activity, through the co-localization of Akt/SGK1 with mTORC2 or another mechanism.”
BackgroundLi, S., Brown, M. S., & Goldstein, J. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914798107 · Cited by 733 · cited 7×
“Sterol response elementbinding protein 1c (SREBP1c) is a transcription factor that regulates the expression of proteins involved in lipid metabolism.”
BackgroundInfluentialDeYoung, M. P., Horak, P., Sofer, A., Sgroi, D., & Ellisen, L. W. (2008) · Genes & Development · doi:10.1101/gad.1617608 · Cited by 710 · cited 1×
“REDD1 can bind 14-3-3 proteins and it is suggested (DeYoung et al., 2008) that REDD1 ‘removes’ the 14-3-3 proteins from the PKB/Akt sites in TSC2, resulting in activation of TSC2 and inhibition of mTORC1.”
BackgroundMayer, C., & Grummt, I. (2006) · Oncogene · doi:10.1038/sj.onc.1209883 · Cited by 568 · cited 12×
“S6Ks may regulate ribosome production by controlling the synthesis of rRNAs, which are transcribed by RNA polymerases I and III (Mayer and Grummt, 2006).”
BackgroundInfluentialSignalling to translation: How signal transduction pathways control the protein synthetic machinery
Proud, C. G. (2007) · Biochemical Journal · doi:10.1042/bj20070024 · Cited by 520 · cited 2×
“There is a further potential link between mTORC1 signaling and autophagy, provided by eEF2K, since mTORC1 negatively regulates eEF2K (Redpath et al., 1996; Proud, 2007) and several reports suggest eEF2K is a positive regulator of autophagy (Wu et al.”
BackgroundDissecting eIF4E action in tumorigenesis
Wendel, H.-G., Silva, R. L. A., Malina, A., Mills, J. R., Zhu, H., Ueda, T., Watanabe-Fukunaga, R., Fukunaga, R., Teruya-Feldstein, J., Pelletier, J., et al. (2007) · Genes & Development · doi:10.1101/gad.1604407 · Cited by 487 · cited 1×
“…question is very high given the body of data showing that overexpression of eIF4E (which may then ‘escape’ control by 4E-BPs) can transform cells, create tumors in mice and is prevalent in human tumors (Lazaris-Karatzas et al., 1990; Ruggero et al., 2004; Wendel et al., 2004, 2007; Fischer, 2009).”
BackgroundRheb Activates mTOR by Antagonizing Its Endogenous Inhibitor, FKBP38
Bai, X., Ma, D., Liu, A., Shen, X., Wang, Q. J., Liu, Y., & Jiang, Y. (2007) · Science · doi:10.1126/science.1147379 · Cited by 382 · cited 1×
“It has also been reported that Rheb binds to FKBP38 (Figure 2), an immunophilin related to FKBP12 (the partner for rapamycin) (Bai et al., 2007).”
BackgroundBEUGNET, A., TEE, A. R., TAYLOR, P. M., & PROUD, C. G. (2003) · Biochemical Journal · doi:10.1042/bj20021266 · Cited by 307 · cited 4×
“Phosphorylation of Ser65 requires the TOR signaling motif (TOS) motif in the C-terminus of 4E-BP1 (Beugnet et al., 2003b).”
BackgroundInfluentialSelf-citationThe choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway.
Korotchkina, L. G., Leontieva, O. V., Bukreeva, E. I., Demidenko, Z. N., Gudkov, A. V., & Blagosklonny, M. V. (2010) · Aging · doi:10.18632/aging.100160 · Cited by 278 · cited 1×
“Recent data indicate that the activation state of mTORC1 signaling plays a role in the processes which lead cells in which p53 has been activated to become quiescent or to senesce (Demidenko et al., 2010; Korotchkina et al., 2010).”
BackgroundParadoxical suppression of cellular senescence by p53
Demidenko, Z. N., Korotchkina, L. G., Gudkov, A. V., & Blagosklonny, M. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002298107 · Cited by 273 · cited 1×
“Recent data indicate that the activation state of mTORC1 signaling plays a role in the processes which lead cells in which p53 has been activated to become quiescent or to senesce (Demidenko et al., 2010; Korotchkina et al., 2010).”
BackgroundSato, T., Nakashima, A., Guo, L., & Tamanoi, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809207200 · Cited by 196 · cited 2×
“So it is unclear what activation of mTORC1 actually means: what effects do agents that stimulate mTORC1 actually have on the complex? Do they increase its intrinsic catalytic activity? Do they cause some rearrangement of its components which enhances its ability to phosphorylate substrates? Interestingly, one recent s…”
BackgroundAverous, J., Fonseca, B. D., & Proud, C. G. (2008) · Oncogene · doi:10.1038/sj.onc.1210715 · Cited by 194 · cited 2×
“mTORC1, and its downstream effector eIF4E, seem to control cyclin D levels through several mechanisms including effects on the levels, stability and translation of its mRNA (Rosenwald et al., 1995; Hashemolhosseini et al., 1998; Averous et al., 2008), and the stability of cyclin D protein (Hashemolhosseini et al.”
BackgroundSelf-citation
Cited by
An update on inflamm-aging: mechanisms, prevention, and treatment
Xia, S., Zhang, X., Zheng, S., Khanabdali, R., Kalionis, B., Wu, J., Wan, W., & Tai, X. (2016) · Journal of Immunology Research · doi:10.1155/2016/8426874 · Cited by 538
Aminoacyl‐tRNA synthetases in medicine and disease
Yao, P., & Fox, P. L. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201100626 · Cited by 274
mTOR: A pathogenic signaling pathway in developmental brain malformations
Crino, P. B. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.07.008 · Cited by 266
Inhibitory effect of mTOR activator MHY1485 on autophagy: suppression of lysosomal fusion
Choi, Y. J., Park, Y. J., Park, J. Y., Jeong, H. O., Kim, D. H., Ha, Y. M., Kim, J. M., Song, Y. M., Heo, H.-S., Yu, B. P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043418 · Cited by 192
Roscic, A., Baldo, B., Crochemore, C., Marcellin, D., & Paganetti, P. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07435.x · Cited by 92
“As mTOR inhibition can interfere with protein synthesis (Wang and Proud 2011), we also tested the effect of BEZ235 without the contribution of protein synthesis to the formation of new aggregates.”
Background
Metadata
- Authors
- Wang, X., & Proud, C. G.
- Venue
- Journal of Molecular Cell Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-12-07
- Volume
- 3
- Issue
- 4
- Pages
- 206-220
- ISSN
- 1674-2788 (ISSN-L)
- OpenAlex
- W2136489332
- Cited by
- 144
- References
- 36
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.